Quick Overview: This session was recorded during the Cholangiocarcinoma Foundation Annual Conference Science Track on May 1, 2026. The Seattle Science Foundation is a not for profit organization dedicated to advancing the quality of patient care through ... Prof McArthur talks to ecancertv at EADO 2015 about the latest from the CoBRIM study. This study looks into predictive and ...

Edward Copelan Md Considers The - Detailed Overview & Context

This session was recorded during the Cholangiocarcinoma Foundation Annual Conference Science Track on May 1, 2026. The Seattle Science Foundation is a not for profit organization dedicated to advancing the quality of patient care through ... Prof McArthur talks to ecancertv at EADO 2015 about the latest from the CoBRIM study. This study looks into predictive and ... Speaker: Kit Curtius (University of California, San Diego) Date: October 1, 2024 The Ecology and Evolution of Cancer: ... Periphery to the Fore – 24th March 2026 Too Many Eosinophils: Unravelling a Multi System Disease An insightful session ... Focus on: Metastatic Urothelial Carcinoma (2026) CME Available: LEARNING ...

Every single cancer treatment you've ever heard of started the exact same way. As a published study that nobody had connected ... For the past fifteen years, Lymphoma & Myeloma has been the premier forum on the latest advances in lymphoma, myeloma, and ...

Photo Gallery

Edward Copelan, MD, considers the role of allogeneic transplantation in lymphoma & multiple myeloma
Edward Copelan, MD, on the most exciting presentations coming out of ASH 2016
Edward Copelan, MD, discusses the Levine Cancer Institute Program
Edward A. Copelan, MD, considers whether azacitidine can be used for induction in AML
Edward A. Copelan, MD, shares highlights from ASH 2017 regarding treatment of acute myeloid leukemia
AC26 - Early Neoplastic Transition States as Targets for Cholangiocarcinoma Prevention, Ed Jarman
Kenneth E. Rosenzweig, MD: 2026 Jacobi Medallion Recipient
A Degenerative Approach to Patients with Spinal Deformity - Christopher Kepler, MD, MBA
Current investigations in the use of allogeneic transplant in the treatment of myeloma
The most promising emerging therapies and developments in PV and ET
When is allogeneic transplant the right answer for MM?
Latest from the CoBRIM study
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored